Clinical Trial Update: A Phase 2 Study to Evaluate the Cardiac and Renal Effects of Short Term Treatment With Elamipretide in Patients Hospitalized With Congestion Due to Heart Failure [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating short-term elamipretide for cardiac and renal effects in patients hospitalized with congestion due to heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Elamipretide (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Heart Failure | Phase 2 | Status: COMPLETED